InvestorsHub Logo
Followers 87
Posts 33387
Boards Moderated 87
Alias Born 03/22/2005

Re: None

Friday, 01/27/2017 10:07:14 AM

Friday, January 27, 2017 10:07:14 AM

Post# of 451
More contrarian value picks -


Biomarin (BMRN) - down from 150 in 2015 to the current 85, this is a great company and is often mentioned as a potential buyout target. They focus on highly profitable drugs for orphan indications.


Express Scripts (ESRX) - another great company, in the pharmacy benefit management area, down from 93 to the current 69. Will have to watch the chart closely though since there might conceivably be a test of the 60 support level, based on the chart.


Novartis (NVS) - the big Swiss pharma, down from 107 to the current 72. Dividend 3.8%. Should it fall more then 60 is key support.


Isramco (ISRL) - this one already rebounded, from 75 to the current 129. The company was started by Israelis in 1982 and they have some core operations in the US, but an intriguing aspect is their participation in the big natural gas discoveries off the coast of Israel. Market cap $350 mil -

http://finance.yahoo.com/news/israeli-group-finds-signs-large-104318132.html



Bank of Greece (NBGGY) - high risk lotto play







Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.